What does a pattern of low immunoglobulin A, high immunoglobulin G, and low immunoglobulin M indicate, and how should it be evaluated and managed?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: March 17, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Evaluation of Low IgA, High IgG, and Low IgM

This immunoglobulin pattern does not fit classic primary immunodeficiency syndromes and requires systematic evaluation to exclude secondary causes, assess functional antibody responses, and determine clinical significance before considering any intervention.

Initial Diagnostic Approach

Confirm the Pattern and Exclude Laboratory Error

  • Repeat all immunoglobulin measurements (IgG, IgA, IgM) at least one month apart to verify persistence, as a single abnormal result is insufficient for diagnosis 1, 2.
  • Measure serum total protein and albumin to exclude protein-losing conditions such as nephrotic syndrome or protein-losing enteropathy that cause secondary hypogammaglobulinemia 2.

Assess for Secondary (Drug-Induced) Causes

  • Review all current and recent medications thoroughly, as drug-induced immunoglobulin abnormalities are often reversible upon discontinuation 1, 2.
  • Specific medications known to cause hypogammaglobulinemia include:
    • Anti-epileptic drugs: phenytoin, carbamazepine, valproic acid, zonisamide 1, 2
    • Rituximab (anti-CD20 therapy) 2
    • Sulfasalazine, gold salts, penicillamine, hydroxychloroquine, NSAIDs 1, 2

Functional Antibody Assessment (Critical Step)

Do not initiate immunoglobulin replacement based solely on immunoglobulin levels; functional antibody responses determine clinical significance 2, 3.

Protein Antigen Responses

  • Evaluate vaccine-induced antibody responses to protein antigens (tetanus, diphtheria) as the primary method to distinguish clinically significant immunodeficiency from benign variations 2, 3.

Polysaccharide Antigen Responses

  • Assess responses to pneumococcal polysaccharide vaccine (Pneumovax-23) in patients older than 6 years 2:
    • Test 2-4 weeks post-vaccination 2
    • Protective response: >1.3 µg/mL for >70% of tested serotypes 1, 2
    • Severe impairment: <2 serotypes reach protective levels 2

B-Cell Quantification and Phenotyping

  • Perform flow cytometry to enumerate total B cells (CD19+) and B-cell subsets, particularly switched memory B cells (CD27+ IgD-) 2.
  • Normal or elevated B-cell counts with this immunoglobulin pattern make agammaglobulinemia extremely unlikely (agammaglobulinemia requires <2% B cells and IgG typically <100 mg/dL) 1, 2.
  • Most patients with common variable immunodeficiency (CVID) have normal B-cell counts despite functional impairment 2.

Pattern-Specific Differential Diagnosis

This Atypical Pattern (Low IgA, High IgG, Low IgM)

  • Classic CVID typically presents with low IgG AND low IgA (IgM may be normal or low); your pattern with elevated IgG is atypical for CVID 2.
  • Consider IgG subclass measurement if recurrent infections are present, as isolated IgG subclass deficiencies can occur with normal total IgG 1.
  • Low IgM with elevated IgG does not suggest hyper-IgM syndrome, which requires elevated or normal IgM with low IgG and IgA 1.

Age Considerations

  • In children younger than 4 years, avoid diagnosing CVID; transient hypogammaglobulinemia of infancy is common and usually resolves spontaneously 1, 2.
  • IgA levels can remain transiently low during infancy and early childhood 1.

Clinical Context and Management Algorithm

If Functional Antibody Responses Are Normal

  • No immunoglobulin replacement therapy is indicated 2.
  • Monitor clinically for development of recurrent infections 1.
  • Repeat immunoglobulin levels periodically to assess for evolution toward a more definitive immunodeficiency 1.

If Functional Antibody Responses Are Impaired AND Recurrent Infections Present

  • Consider aggressive antimicrobial therapy and prophylactic antibiotics as first-line management 1, 2.
  • Target common pathogens: encapsulated bacteria (Streptococcus pneumoniae, Haemophilus influenzae) and atypical organisms (Mycoplasma, Ureaplasma) 1, 2.
  • Reserve immunoglobulin replacement therapy only for patients with documented impaired vaccine responses AND recurrent infections that negatively affect quality of life despite aggressive antimicrobial management 2.

Additional Imaging

  • Obtain thoraco-abdominal CT scanning to identify thymoma (Good syndrome), lymphoma, splenomegaly, or lymphadenopathy that may underlie secondary immunodeficiency 2.

Key Clinical Pitfalls

  • Never diagnose primary immunodeficiency based on a single abnormal immunoglobulin measurement 1, 2.
  • The elevated IgG in this pattern argues strongly against most primary immunodeficiencies and should prompt thorough investigation for secondary causes 2.
  • Approximately 2.5% of the population will have at least one immunoglobulin level below the normal range by statistical definition alone 1.
  • Medication-induced changes are frequently overlooked but often reversible 1, 2.
  • Sustained very low IgM (<20 mg/dL) for prolonged periods increases infection risk, but transient or moderate reductions are generally well tolerated 4.

References

Guideline

practice parameter for the diagnosis and management of primary immunodeficiency.

Journal of Allergy and Clinical Immunology, 2015

Guideline

Workup and Diagnosis of Low IgG and Low IgM

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2026

Research

How to use immunoglobulin levels in investigating immune deficiencies.

Archives of disease in childhood. Education and practice edition, 2016

Research

Serum immunoglobulins and risk of infection: how low can you go?

Seminars in arthritis and rheumatism, 2009

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.